| Literature DB >> 30579716 |
Eduardo Anitua1, Roberto Prado2.
Abstract
Stem cell and platelet-rich plasma (PRP) therapies are promising breakthroughs in the treatment of multiple conditions. However, the lack of reproducibility due to inaccurate reporting of the protocols used to obtain these biologics can hinder their therapeutic progress. A reporting guideline for biological therapies is required to address this issue.Keywords: CONSORT; EQUATOR; biological therapies; platelet-rich plasma; reporting guidelines; stem cell
Year: 2018 PMID: 30579716 DOI: 10.1016/j.tibtech.2018.11.010
Source DB: PubMed Journal: Trends Biotechnol ISSN: 0167-7799 Impact factor: 19.536